214 related articles for article (PubMed ID: 12538662)
21. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
Palmer LD; Saha B; Hodes RJ; Abe R
J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
[TBL] [Abstract][Full Text] [Related]
22. RIII/Sa mice with a high incidence of mammary tumors express two exogenous strains and one potential endogenous strain of mouse mammary tumor virus.
Sarkar NH; Golovkina T; Uz-Zaman T
J Virol; 2004 Jan; 78(2):1055-62. PubMed ID: 14694140
[TBL] [Abstract][Full Text] [Related]
23. Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens.
Bhadra S; Lozano MM; Payne SM; Dudley JP
PLoS Pathog; 2006 Dec; 2(12):e128. PubMed ID: 17140288
[TBL] [Abstract][Full Text] [Related]
24. [Superantigens and retroviral infections. Increase of mammary tumorigenicity due to recombination between exogenous and endogenous MMTV viruses].
Nepomnaschy I; Buggiano V; Goldman A; Deroche A; Bekinschtein P; Berguer P; Piazzon I
Medicina (B Aires); 1997; 57(3):327-31. PubMed ID: 9640768
[TBL] [Abstract][Full Text] [Related]
25. Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.
Buggiano V; Goldman A; Nepomnaschy I; Bekinschtein P; Berguer P; Lombardi G; Deroche A; Francisco MV; Piazzon I
Scand J Immunol; 1999 Mar; 49(3):269-77. PubMed ID: 10102644
[TBL] [Abstract][Full Text] [Related]
26. C3H/HeN mammary tumor-bearing mice develop type-specific neutralizing antibodies and group-specific precipitating antibodies for the mouse mammary tumor virus.
Massey R; Arthur LO; Long CW; Schochetman G
J Virol; 1980 Jan; 33(1):123-8. PubMed ID: 6154146
[TBL] [Abstract][Full Text] [Related]
27. Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model.
Ardavin C; Luthi F; Andersson M; Scarpellino L; Martin P; Diggelmann H; Acha-Orbea H
J Virol; 1997 Oct; 71(10):7295-9. PubMed ID: 9311805
[TBL] [Abstract][Full Text] [Related]
28. Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells.
Luther SA; Maillard I; Luthi F; Scarpellino L; Diggelmann H; Acha-Orbea H
J Immunol; 1997 Sep; 159(6):2807-14. PubMed ID: 9300703
[TBL] [Abstract][Full Text] [Related]
29. APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions.
Okeoma CM; Huegel AL; Lingappa J; Feldman MD; Ross SR
Cell Host Microbe; 2010 Dec; 8(6):534-43. PubMed ID: 21147467
[TBL] [Abstract][Full Text] [Related]
30. Increases in IgA(+) B cells in Peyer's patches during milk-borne mouse mammary tumor virus infection are influenced by Toll-like receptor 4 and are completely dependent on the superantigen response.
Cabrera G; Vercelli C; Burzyn D; Badano N; Maglioco A; Costa H; Mundiñano J; Camicia G; Nepomnaschy I; Piazzon I
J Gen Virol; 2010 Nov; 91(Pt 11):2814-20. PubMed ID: 20685932
[TBL] [Abstract][Full Text] [Related]
31. Mouse mammary tumor virus (MMTV), a retrovirus that exploits the immune system. Genetics of susceptibility to MMTV infection.
Ross SR; Dzuris JL; Golovkina TV; Clemmons WC; van den Hoogen B
Medicina (B Aires); 1997; 57 Suppl 2():34-42. PubMed ID: 9567342
[TBL] [Abstract][Full Text] [Related]
32. APOBEC3 inhibition of mouse mammary tumor virus infection: the role of cytidine deamination versus inhibition of reverse transcription.
MacMillan AL; Kohli RM; Ross SR
J Virol; 2013 May; 87(9):4808-17. PubMed ID: 23449789
[TBL] [Abstract][Full Text] [Related]
33. The nasal-associated lymphoid tissue of adult mice acts as an entry site for the mouse mammary tumor retrovirus.
Velin D; Fotopoulos G; Luthi F; Kraehenbuhl JP
J Exp Med; 1997 May; 185(10):1871-6. PubMed ID: 9151713
[TBL] [Abstract][Full Text] [Related]
34. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
Santiago ML; Montano M; Benitez R; Messer RJ; Yonemoto W; Chesebro B; Hasenkrug KJ; Greene WC
Science; 2008 Sep; 321(5894):1343-6. PubMed ID: 18772436
[TBL] [Abstract][Full Text] [Related]
35. Neonatal infection with a milk-borne virus is independent of beta7 integrin- and L-selectin-expressing lymphocytes.
Czarneski J; Berguer P; Bekinschtein P; Kim DC; Hakimpour P; Wagner N; Nepomnaschy I; Piazzon I; Ross SR
Eur J Immunol; 2002 Apr; 32(4):945-56. PubMed ID: 11920560
[TBL] [Abstract][Full Text] [Related]
36. Passive immunization with neutralizing antibodies interrupts the mouse mammary tumor virus life cycle.
Mpandi M; Otten LA; Lavanchy C; Acha-Orbea H; Finke D
J Virol; 2003 Sep; 77(17):9369-77. PubMed ID: 12915552
[TBL] [Abstract][Full Text] [Related]
37. Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models.
Zhang G; Chen M; Graham D; Subsin B; McDougall C; Gilady S; Kneteman M; Law L; Swain M; Trauner M; Wrzesinski S; Flavell R; Wasilenko S; Mason A
J Hepatol; 2011 Oct; 55(4):876-84. PubMed ID: 21334408
[TBL] [Abstract][Full Text] [Related]
38. Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection.
Golovkina TV; Prescott JA; Ross SR
J Virol; 1993 Dec; 67(12):7690-4. PubMed ID: 8230492
[TBL] [Abstract][Full Text] [Related]
39. Superantigens of mouse mammary tumor virus.
Acha-Orbea H; MacDonald HR
Annu Rev Immunol; 1995; 13():459-86. PubMed ID: 7612231
[TBL] [Abstract][Full Text] [Related]
40. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
